Progression to type 2 diabetes mellitus and associated risk factors after hyperglycemia first detected in pregnancy: A cross-sectional study in Cape Town, South Africa

English version

Autoři: Tawanda Chivese ^aff001; Shane A. Norris ^aff002; Naomi S. Levitt ^aff001
Působiště autorů: Chronic Disease Initiative for Africa, Department of Medicine, Faculty of Medicine and Health Sciences, University of Cape Town, Cape Town, South Africa ^aff001; SAMRC/Wits Developmental Pathways for Health Research Unit, Department of Paediatrics, Faculty of Medicine and Health Sciences, University of the Witwatersrand, Johannesburg, South Africa ^aff002
Vyšlo v časopise: Progression to type 2 diabetes mellitus and associated risk factors after hyperglycemia first detected in pregnancy: A cross-sectional study in Cape Town, South Africa. PLoS Med 16(9): e32767. doi:10.1371/journal.pmed.1002865
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1002865

Souhrn

Background

Global data indicate that women with a history of hyperglycemia first detected in pregnancy (HFDP) are at up to 7 times risk of progressing to type 2 diabetes mellitus (T2DM) compared with their counterparts who have pregnancies that are not complicated by hyperglycemia. However, there are no data from the sub-Saharan African region, which has the highest projected rise in diabetes prevalence globally. The aim of this study was to determine the proportion of women who progress to T2DM and associated risk factors 5 to 6 years after HFDP in Cape Town, South Africa.

Methods and findings

All women with HFDP, at a major referral hospital in Cape Town, were followed up 5 to 6 years later using a cross-sectional study. Each participant had a 75 g oral glucose tolerance test; anthropometric measurements and a survey were administered. A total of 220 participants were followed up. At this time, their mean age was 37.2 years (SD 6.0). Forty-eight percent (95% CI 41.2–54.4) progressed to T2DM, 5.5% (95% CI 3.1–9.4) had impaired fasting glucose, and 10.5% (95% CI 7.0–15.3) had impaired glucose tolerance. Of the participants who progressed to T2DM, 47% were unaware of their diabetes status. When HFDP was categorized post hoc according to WHO 2013 guidelines, progression in the diabetes in pregnancy (DIP) group was 81% (95% CI 70.2–89.0) and 31.3% (95% CI 24.4–39.3) in the gestational diabetes mellitus (GDM) category. Factors associated with risk of progression to T2DM were; at follow-up: waist circumference (odds ratios [OR] 1.1, 95% CI 1.0–1.1, p = 0.007), hip circumference (OR 0.9, 95% CI 0.8–1.0, p = 0.001), and BMI (OR 1.1, 95% CI 1.0–1.3, p = 0.001), and at baseline: insulin (OR 25.8, 95% CI 3.9–171.4, p = 0.001) and oral hypoglycaemic treatment during HFDP (OR 4.1, 95% CI 1.3–12.9, p = 0.018), fasting (OR 2.7, 95% CI 1.5–4.8, p = 0.001), and oral glucose tolerance test 2-hour glucose concentration at HFDP diagnosis (OR 4.3, 95% CI 2.4–7.7, p < 0.001). Our findings have limitations in that we did not include a control group of women without a history of HFDP.

Conclusions

The progression to T2DM in women with previous HFDP found in this study highlights the need for interventions to delay or prevent progression to T2DM after HFDP. In addition, interventions to prevent HFDP may also contribute to reducing the risk of T2DM.

Klíčová slova:

Body Mass Index – Biology and life sciences – People and places – Geographical locations – Medicine and health sciences – Physiology – Physiological parameters – Women's health – Maternal health – Obstetrics and gynecology – Diagnostic medicine – Endocrinology – Endocrine disorders – Metabolic disorders – Hyperglycemia – Pregnancy – Pharmacology – Pharmacologic-based diagnostics – Oral glucose suppression test – Glucose tolerance tests – Body weight – Africa – South Africa

Zdroje

1. Rahelic D. 7th Edition of Idf Diabetes Atlas—Call for Immediate Action. Lijecnicki vjesnik. 2016;138(1–2):57–8. 27290816

2. Statistics South Africa. P0309.3—Mortality and causes of death in South Africa: Findings from death notification, 2016. 2018.

3. Kengne AP, Bentham J, Zhou B, Peer N, Matsha TE, Bixby H, et al. Trends in obesity and diabetes across Africa from 1980 to 2014: an analysis of pooled population-based studies. International journal of epidemiology. 2017.

4. Puoane T, Steyn K, Bradshaw D, Laubscher R, Fourie J, Lambert V, et al. Obesity in South Africa: the South African demographic and health survey. Obesity research. 2002;10(10):1038–48. doi: 10.1038/oby.2002.141 12376585

5. Department of Health South Africa. World Obesity Day 2016. 2016. Available from: http://www.health.gov.za/index.php/gf-tb-program/323-world-obesity-day-2016. [cited 2019 January 30].

6. Goedecke JH, Mtintsilana A, Dlamini SN, Kengne AP. Type 2 diabetes mellitus in African women. Diabetes research and clinical practice. 2017;123:87–96. doi: 10.1016/j.diabres.2016.11.017 28006698

7. Bellamy L, Casas J-P, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. The Lancet. 2009;373(9677):1773–9.

8. International Association of Diabetes Pregnancy Study Groups Consensus Panel. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes care. 2010;33(3):676–82. doi: 10.2337/dc09-1848 20190296

9. HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, et al. Pregnancy Outcome (HAPO) Study Cooperative Research Group. N Engl J Med. 2008;358:991–2002. doi: 10.1056/NEJMoa073785

10. World Health Organization. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. 2013.

11. Lowe WL, Scholtens DM, Lowe LP, Kuang A, Nodzenski M, Talbot O, et al. Association of Gestational Diabetes With Maternal Disorders of Glucose Metabolism and Childhood Adiposity. JAMA. 2018;320(10):1005–16. doi: 10.1001/jama.2018.11628 30208453

12. Zhu Y, Zhang C. Prevalence of Gestational Diabetes and Risk of Progression to Type 2 Diabetes: a Global Perspective. Current diabetes reports. 2016;16(1):7. doi: 10.1007/s11892-015-0699-x 26742932

13. Ma RCW, Tsoi KY, Tam WH, Wong CKC. Developmental origins of type 2 diabetes: a perspective from China. European journal of clinical nutrition. 2017;71(7):870–80. doi: 10.1038/ejcn.2017.48 28378847

14. Zhu Y, Zhang C. Prevalence of Gestational Diabetes and Risk of Progression to Type 2 Diabetes: a Global Perspective. Current diabetes reports. 2016;16(1):7-015-0699-x.

15. Macaulay S, Dunger DB, Norris SA. Gestational diabetes mellitus in Africa: a systematic review. PLoS ONE. 2014;9(6):e97871. doi: 10.1371/journal.pone.0097871 24892280

16. Olagbuji BN, Atiba AS, Olofinbiyi BA, Akintayo AA, Awoleke JO, Ade-Ojo IP, et al. Prevalence of and risk factors for gestational diabetes using 1999, 2013 WHO and IADPSG criteria upon implementation of a universal one-step screening and diagnostic strategy in a sub-Saharan African population. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2015;189:27–32.

17. Pastakia SD, Njuguna B, Ajwang’Onyango B, Washington S, Christoffersen-Deb A, Kosgei WK, et al. Prevalence of gestational diabetes mellitus based on various screening strategies in western Kenya: a prospective comparison of point of care diagnostic methods. BMC pregnancy and childbirth. 2017;17(1):226. doi: 10.1186/s12884-017-1415-4 28705184

18. Macaulay S, Ngobeni M, Dunger DB, Norris SA. The prevalence of gestational diabetes mellitus amongst black South African women is a public health concern. Diabetes research and clinical practice. 2018;139:278–87. doi: 10.1016/j.diabres.2018.03.012 29526682

19. Adams S, Rheeder P. Screening for gestational diabetes mellitus in a South African population: prevalence, comparison of diagnostic criteria and the role of risk factors. South African Medical Journal. 2017;107(6):523–7. doi: 10.7196/SAMJ.2017.v107i6.12043 28604326

20. Song C, Lyu Y, Li C, Liu P, Li J, Ma R, et al. Long‐term risk of diabetes in women at varying durations after gestational diabetes: a systematic review and meta‐analysis with more than 2 million women. Obesity reviews. 2018;19(3):421–9. doi: 10.1111/obr.12645 29266655

21. Chamberlain CR, Oldenburg B, Wilson AN, Eades SJ, O'Dea K, Oats JJ, et al. Type 2 diabetes after gestational diabetes: greater than fourfold risk among Indigenous compared with non-Indigenous Australian women. Diabetes/metabolism research and reviews. 2016;32(2):217–27. doi: 10.1002/dmrr.2715 26385131

22. Gupta Y, Kapoor D, Desai A, Praveen D, Joshi R, Rozati R, et al. Conversion of gestational diabetes mellitus to future Type 2 diabetes mellitus and the predictive value of HbA1c in an Indian cohort. Diabetic medicine: a journal of the British Diabetic Association. 2017;34(1):37–43.

23. Rayanagoudar G, Hashi AA, Zamora J, Khan KS, Hitman GA, Thangaratinam S. Quantification of the type 2 diabetes risk in women with gestational diabetes: a systematic review and meta-analysis of 95,750 women. Springer; 2016.

24. Coetzee A, Mason D, Hall DR, Conradie M. Prevalence and predictive factors of early postpartum diabetes among women with gestational diabetes in a single‐center cohort. International Journal of Gynecology & Obstetrics. 2018.

25. Van Zyl H, Levitt N. Pregnancy outcome in patients with pregestational and gestational diabetes attending Groote Schuur Hospital, Cape Town, South Africa. South African Medical Journal. 2018;108(9).

26. Maternal Guideline Reference Group and the Subcommittee of the Society for Maternal and Foetal Medicine in South Africa. Diabetes in Pregnancy, Provincial Guideline of the Western Cape, for the Management of Diabetes and Its Complications from Pre-conception to the Postnatal Period. In: Government WCP, editor. 2010.

27. Guideline Development Group. Guidelines: management of diabetes from preconception to the postnatal period: summary of NICE guidance. BMJ: British Medical Journal. 2008;336(7646):714. doi: 10.1136/bmj.39505.641273.AD 18369227

28. World Health Organization. Obesity and overweight 2015. Available from: http://www.who.int/mediacentre/factsheets/fs311/en/. [cited 2019 30 January].

29. World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia—Report of a WHO/IDF consultation 2006. Available from: http://www.who.int/diabetes/publications/diagnosis_diabetes2006/en/. [cited 2019 January 30].

30. Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes care. 2002;25(10):1862–8. doi: 10.2337/diacare.25.10.1862 12351492

31. Stata C. College Station (TX). Stata Press. 2016.

32. Huvinen E, Eriksson JG, Koivusalo SB, Grotenfelt N, Tiitinen A, Stach-Lempinen B, et al. Heterogeneity of gestational diabetes (GDM) and long-term risk of diabetes and metabolic syndrome: findings from the RADIEL study follow-up. Acta Diabetol. 2018;55(5):493–501. doi: 10.1007/s00592-018-1118-y 29460080

33. Simmons D, Kumar S, Crook N, Rush E. Diabetes among Maori women with self-reported past gestational diabetes mellitus in a New Zealand Maori community. The Australian & New Zealand journal of obstetrics & gynaecology. 2017;57(6):599–603.

34. Chamberlain CR, Oldenburg B, Wilson AN, Eades SJ, O'Dea K, Oats JJ, et al. Type 2 diabetes after gestational diabetes: greater than fourfold risk among Indigenous compared with non-Indigenous Australian women. Diabetes Metab Res Rev. 2016;32(2):217–27. doi: 10.1002/dmrr.2715 26385131

35. Tam WH, Yang XL, Chan JC, Ko GT, Tong PC, Ma RC, et al. Progression to impaired glucose regulation, diabetes and metabolic syndrome in Chinese women with a past history of gestational diabetes. Diabetes/metabolism research and reviews. 2007;23(6):485–9. doi: 10.1002/dmrr.741 17410525

36. Wang Y, Chen L, Horswell R, Xiao K, Besse J, Johnson J, et al. Racial differences in the association between gestational diabetes mellitus and risk of type 2 diabetes. Journal of women's health (2002). 2012;21(6):628–33.

37. Madarász E, Tamás G, Tabák ÁG, Kerényi Z. Carbohydrate metabolism and cardiovascular risk factors 4 years after a pregnancy complicated by gestational diabetes. Diabetes research and clinical practice. 2009;85(2):197–202. doi: 10.1016/j.diabres.2009.05.001 19481830

38. Lee H, Jang HC, Park HK, Metzger BE, Cho NH. Prevalence of type 2 diabetes among women with a previous history of gestational diabetes mellitus. Diabetes research and clinical practice. 2008;81(1):124–9. doi: 10.1016/j.diabres.2008.02.017 18456364

39. Lee H, Jang HC, Park HK, Metzger BE, Cho NH. Prevalence of type 2 diabetes among women with a previous history of gestational diabetes mellitus. Diabetes Res Clin Pract. 2008;81(1):124–9. doi: 10.1016/j.diabres.2008.02.017 18456364

40. Rivero K, Portal VL, Vieira M, Behle I. Prevalence of the impaired glucose metabolism and its association with risk factors for coronary artery disease in women with gestational diabetes. Diabetes Res Clin Pract. 2008;79(3):433–7. doi: 10.1016/j.diabres.2007.10.015 18045723

41. Tam WH, Ma RC, Yang X, Ko GT, Lao TT, Chan MH, et al. Cardiometabolic risk in Chinese women with prior gestational diabetes: a 15-year follow-up study. Gynecologic and obstetric investigation. 2012;73(2):168–76. doi: 10.1159/000329339 22179684

42. Krishnaveni GV, Hill JC, Veena SR, Geetha S, Jayakumar MN, Karat CLS, et al. Gestational diabetes and the incidence of diabetes in the 5 years following the index pregnancy in South Indian women. Diabetes research and clinical practice. 2007;78(3):398–404. doi: 10.1016/j.diabres.2007.06.002 17640759

43. Kale S, Yajnik C, Kulkarni S, Meenakumari K, Joglekar A, Khorsand N, et al. High risk of diabetes and metabolic syndrome in Indian women with gestational diabetes mellitus. Diabetic medicine. 2004;21(11):1257–8. doi: 10.1111/j.1464-5491.2004.01337.x 15498096

44. Tam WH, Ma RC, Yang X, Ko GT, Tong PC, Cockram CS, et al. Glucose intolerance and cardiometabolic risk in children exposed to maternal gestational diabetes mellitus in utero. Pediatrics. 2008;122(6):1229–34. doi: 10.1542/peds.2008-0158 19047239

45. Simmons D, McElduff A, McIntyre HD, Elrishi M. Gestational diabetes mellitus: NICE for the U.S.? A comparison of the American Diabetes Association and the American College of Obstetricians and Gynecologists guidelines with the U.K. National Institute for Health and Clinical Excellence guidelines. Diabetes care. 2010;33(1):34–7. doi: 10.2337/dc09-1376 19837790

46. Gupta Y, Kapoor D, Desai A, Praveen D, Joshi R, Rozati R, et al. Conversion of gestational diabetes mellitus to future Type 2 diabetes mellitus and the predictive value of HbA1c in an Indian cohort. Diabet Med. 2017;34(1):37–43. doi: 10.1111/dme.13102 26926329

47. Inoue H, Ishikawa K, Takeda K, Kobayashi A, Kurita K, Kumagai J, et al. Postpartum risk of diabetes and predictive factors for glucose intolerance in East Asian women with gestational diabetes. Diabetes research and clinical practice. 2018;140:1–8. doi: 10.1016/j.diabres.2018.03.031 29596944

48. Shisana O, Labadarios D, Rehle T, Simbayi L, Zuma K, Dhansay A, et al. The South African National Health and Nutrition Examination Survey, 2012: SANHANES-1: the health and nutritional status of the nation. 2014.

49. Peer N, Steyn K, Lombard C, Lambert EV, Vythilingum B, Levitt NS. Rising diabetes prevalence among urban-dwelling black South Africans. PLoS ONE. 2012;7(9):e43336. doi: 10.1371/journal.pone.0043336 22962583

50. Erasmus RT, Soita DJ, Hassan MS, Blanco-Blanco E, Vergotine Z, Kengne AP, et al. High prevalence of diabetes mellitus and metabolic syndrome in a South African coloured population: Baseline data of a study in Bellville, Cape Town. SAMJ: South African Medical Journal. 2012;102(11):841–4.

51. Venkataraman H, Sattar N, Saravanan P. Postnatal testing following gestational diabetes: time to replace the oral glucose tolerance test? The Lancet Diabetes & Endocrinology. 2015;3(10):754–6.

52. Mayosi BM, Benatar SR. Health and Health Care in South Africa—20 Years after Mandela. New England Journal of Medicine. 2014;371(14):1344–53. doi: 10.1056/NEJMsr1405012 25265493

53. Madarasz E, Tamas G, Tabak AG, Kerenyi Z. Carbohydrate metabolism and cardiovascular risk factors 4 years after a pregnancy complicated by gestational diabetes. Diabetes Res Clin Pract. 2009;85(2):197–202. doi: 10.1016/j.diabres.2009.05.001 19481830

54. Kale SD, Yajnik CS, Kulkarni SR, Meenakumari K, Joglekar AA, Khorsand N, et al. High risk of diabetes and metabolic syndrome in Indian women with gestational diabetes mellitus. Diabet Med. 2004;21(11):1257–8. doi: 10.1111/j.1464-5491.2004.01337.x 15498096

55. Krishnaveni GV, Hill JC, Veena SR, Geetha S, Jayakumar MN, Karat CL, et al. Gestational diabetes and the incidence of diabetes in the 5 years following the index pregnancy in South Indian women. Diabetes research and clinical practice. 2007;78(3):398–404. doi: 10.1016/j.diabres.2007.06.002 17640759

56. Tomkin G, Owens D. Diabetes and dyslipidemia: characterizing lipoprotein metabolism. Diabetes, metabolic syndrome and obesity: targets and therapy. 2017;10:333.

57. Association AD. Standards of medical care in diabetes—2016 abridged for primary care providers. Clinical diabetes: a publication of the American Diabetes Association. 2016;34(1):3.

58. Gante I, Ferreira AC, Pestana G, Pires D, Amaral N, Dores J, et al. Maternal educational level and the risk of persistent post-partum glucose metabolism disorders in women with gestational diabetes mellitus. Acta Diabetol. 2018;55(3):243–51. doi: 10.1007/s00592-017-1090-y 29288374

59. Statistics South Africa. Mid-year population estimates 2018 2018. Available from: http://www.statssa.gov.za/publications/P0302/P03022018.pdf. [cited 2019 1 March 2019]